Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review

• Main Authors: A. V. Kryukov (Author), A. S. Zhiryakova (Author), Yu. V. Shevchuk (Author), A. V. Matveev (Author), V. I. Vechorko (Author), O. V. Averkov (Author), S. V. Glagolev (Author), I. I. Temirbulatov (Author), K. B. Mirzaev (Author), N. P. Denisenko (Author), Sh. P. Abdullaev (Author), D. A. Sychev (Author)
• Format: Book
• Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The safety of COVID-19 pharmacotherapy is a relevant issue, first of all, because of the current lack of experience with using particular medicinal products and with off-label prescribing. The aim of the study was to analyse information on potential adverse drug reactions (ADRs) and their predictors...